L&K Biomed Ltd. (KOSDAQ:156100)

Market Cap	129.86B -0.1%
Revenue (ttm)	38.92B +7.8%
Net Income	-16.30B
EPS	-801.67
Shares Out	22.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	294,850
Average Volume	308,136
Open	5,810.00
Previous Close	5,800.00
Day's Range	5,490.00 - 5,940.00
52-Week Range	5,400.00 - 16,400.00
Beta	n/a
RSI	27.29
Earnings Date	May 21, 2026

About L&K Biomed

L&K Biomed Ltd., a medical company, manufactures and sells spinal implants in South Korea, the United States, Thailand, and internationally. The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach; and PathLoc-TA, an expandable ALIF anterior ...

• Founded: 2008
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 156100